All Type of News
Foreign makers beef up OTC business
Some foreign makers of over-the-counter (OTC) drugs are seeking a breakthrough in the local still-sagging non-prescription medication field.
Reckitt Benckiser, Wyeth and Johnson & Johnson are waging fiercer marketi...
GlaxoSmithKline confirms presence of material from PCV-1 virus in Rotarix
GlaxoSmithKline (GSK) confirmed on March 22 that it has notified the Korea Food and Drug Administration of the presence of material from a virus called PCV-1 in its oral rotavirus vaccine, Rotarix.
PCV-1 does not ...
Health insurance to save 4.8 billion won under DUR system
The national health insurance may save its annual medication costs by approximately 4.8 billion won if the Drug Utilization Review (DUR) system is implemented nationwide, according to the Health Insurance Review and A...
New drug-pricing reform triggers protests
The government announced its move to legislate a new drug pricing policy by October and pledged to take bolder steps to rid medical sector of corrupt practices.
The announcement triggered immediate denunciation fro...
A doctor group calls for medical treatment rights
A local doctor group claimed that the government should protect its professional right and reduce the current generic drug prices.
In an advertisement carried in a local newspaper on March 23, the National Union fo...
Drug makers urged to step up self-purification efforts
Korean pharmaceutical firms should be encouraged to voluntarily make changes through strict application of the fair trade code as part of their efforts to persuade the government to scrap the plan to provide cash rewa...
“Independent chain” network for drug distribution contemplated
A major change in Korea’s drug distribution for pharmaceuticals is in the making as major domestic wholesalers, including Geoyoung and Dongwon Pharma, plan to step up their “independent chain” networks to boost their ...
Daewoong enters agreement with Medivir for MIV-210, hepatitis B and HIV therapy
Daewoong Pharm announced on March 22 that it has signed an exclusive license and supply agreement with Medivir AB, a Sweden based pharmaceutical company, for a novel hepatitis B virus (HBV) polymerase inhibitor drug, ...
Double inspection effective for successful implementation of DUR system
Doctors and pharmacists should be cooperative in the successful implementation of the Drug Utilization Review (DUR) system, according to the Health Insurance Review and Assessment Service (HIRAS).
Citing the resear...
Chong Kun Dang releases multivitamin preparations
Chong Kun Dang Pharmaceutical Co. has recently marketed a series of three different multivitamin tablets (Incolamin Premier, Q10 and Join-up) containing a variety of nutrients including fursultiamine HCl, vitamin grou...
